Detalhe da pesquisa
1.
Fracture Liaison Services in India: Challenges and Opportunities.
J Assoc Physicians India
; 71(12): 11-13, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736047
2.
Simplifying Type 2 DM Care with Linagliptin: A Position Paper.
J Assoc Physicians India
; 71(8): 11-12, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651251
3.
Role and Significance of Dietary Protein in the Management of Type 2 Diabetes and Its Complications in India: An Expert Opinion.
J Assoc Physicians India
; 71(12): 36-46, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736053
4.
Demographic and clinical profile of youth onset diabetes patients in India-Results from the baseline data of a clinic based registry of people with diabetes in India with young age at onset-[YDR-02].
Pediatr Diabetes
; 22(1): 15-21, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31885113
5.
Indian Expert Review on Use of Teneligliptin in patients with Diabetes and its Safety and Efficacy (INTENSE).
J Assoc Physicians India
; 69(1): 61-70, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34227778
6.
Laparoscopic resection of a large paraganglioma arising in the organ of Zuckerkandl: Report of a case and review of the literature.
J Minim Access Surg
; 12(4): 378-81, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27251804
7.
Role of Telemedicine in Diabetes Management.
J Diabetes Sci Technol
; 17(3): 775-781, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227105
8.
Differences in the Presentation and Outcome between Premenopausal and Postmenopausal Primary Hyperparathyroidism Indian Women: A Single-Center Experience.
J Midlife Health
; 14(2): 73-80, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029031
9.
Evolution of Guideline Recommendations on Insulin Therapy in Type 2 Diabetes Mellitus Over the Last Two Decades: A Narrative Review.
Curr Diabetes Rev
; 19(8): e160123212777, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650625
10.
Differences in the Clinical Presentation and Biochemical Profile of the Patients with Primary Hyperparathyroidism with regard to their Serum Vitamin D Levels: a Single-center Experience.
Indian J Surg Oncol
; 14(2): 301-307, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37324304
11.
LIVE INDIA: Effectiveness of Gla-100 in a Post hoc Pooled Analysis of FINE ASIA and GOAL Registries.
Diabetes Ther
; 14(12): 2075-2088, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789213
12.
Indian College of Physicians Position Statement on Anemia in Metabolic Syndrome.
J Assoc Physicians India
; 65(6): 60-73, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782315
13.
Prevalence of Bacterial Urinary Tract Infection Among Patients With Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter-2 Inhibitors: A Prospective Real-World Setting Study.
J ASEAN Fed Endocr Soc
; 37(2): 5-8, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578886
14.
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting.
Diabetes Ther
; 13(5): 1097-1114, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35334083
15.
A Case Presentation.
Endocr Pract
; 22(3): 375, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26536139
16.
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1.
J Assoc Physicians India
; 64(3 suppl): 7-52, 2016 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28762263
17.
The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.
Arch Osteoporos
; 16(1): 102, 2021 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176015
18.
Tumor-induced osteomalacia: experience from three tertiary care centers in India.
Endocr Connect
; 8(3): 266-276, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30726771
19.
Lilly Insulin Glargine Versus Lantus® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study.
Clin Drug Investig
; 39(8): 745-756, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31119716
20.
Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus.
Indian J Endocrinol Metab
; 22(6): 827-836, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30766826